Option Care Health, Inc. (OPCH)
NASDAQ • Healthcare
Last close at October 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Option Care Health, Inc. keeps $4 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 25 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Option Care Health topped expectations on both the top and bottom line in the second fiscal quarter of 2026, reported July 29, as revenue rose 1.9% to about $1.44 billion and adjusted EPS of $0.45 topped the about $1.42 billion estimate by about +2%. Net income rose 6.7% to about $53.9 million from $50.5 million a year earlier, while operating income came in at about $85.1 million; gross margin was about 19% and operating margin about 6%. The company generated operating cash flow of $183.6 million and repurchased $153.0 million of stock, and consensus for the next period calls for EPS of $0.48 on revenue of $1.47 billion.
Next report — what to expect
Option Care Health, Inc. (OPCH) reports on October 29, 2026. Wall Street is looking for EPS of $0.48 on revenue of $1.47 billion. For trailing context, revenue grew +1.9% year over year last quarter. OPCH has beaten EPS in 6 of its 8 most recent quarters.
About Option Care Health, Inc.
Option Care Health, Inc. (NASDAQ: OPCH) provides home and alternate-site infusion care in the U.S. healthcare services market, pairing specialized infusion treatments with professional nursing support. The company generated $5.6 billion in revenue in FY2025 and operates as a care provider centered on therapies delivered outside the hospital.
Today's Snapshot
The day ended with OPCH slightly higher at 31.07, while its sector was firmer. Trading was lighter than usual, with volume about half of its usual level. Option Care Health agreed to be bought by McKesson, a drug distributor, and Clayton, Dubilier & Rice, a private-equity firm.
Trading Volume
Below 10d avg (11.1M)
6M
vs S&P 500 Today
Underperforming Market
-0.53%
Updated: October 9, 2026 at 20:19 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$24.23 - $27.47Buy
- RSI (14)83.80Sell
- Stochastic %K (14, 3, 3)99.24Sell
- MACD Level (12, 26)1.60Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.